Multiple-dose pharmacokinetics and pharmacodynamics of OROS and immediate-release amitriptyline hydrochloride formulations

Journal of Clinical Pharmacology

Volumn 38, Issue 1, 1998, Pages 60-67

  Gupta, Suneel K ^a   Shah, Jaymin ^a   Guinta, Diane ^a   Hwang, Stephen ^a  

^a ALZA CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; NORTRIPTYLINE;

ADULT; ANTICHOLINERGIC EFFECT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG BLOOD LEVEL; DRUG FORMULATION; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HYSTERESIS; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; TABLET; XEROSTOMIA;

EID: 0031885486     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1998.tb04378.x     Document Type: Article

References (13)

1. 1 receptors. Mayo Clin Proc 1979;54:669-674.
2. Knorring L, Mornstad H, Forsgren L, Holmgren S: Acute effects of different antidepressant drugs on saliva secretion and accommodation range. Pharmacopsychiatry 1986;19:106-110.
3. Chose K, Sedman E: A double-blind comparison of the pharmacodynamic effects of single doses of lofepramine, amitriptyline and placebo in elderly subjects. Eur J Clin Pharmacol 1987;33:505-509.
4. Nakano S, Hollister LE: Chronopharmacology of amitriptyline. Clin Pharmacol Ther 1983;33:453-459.
5. Schulz P, Turner-Tamiyasu K, Smith G, Giacomini KM, Blaschke TF: Amitriptyline disposition in young and elderly normal men. Clin Pharmacol Ther 1983;33:360-366.
6. Weise CC, Stein MK, Pereira-Ogan J, Csenalosi I, Rickels K: Amitriptyline once-daily vs. three times daily in depressed outpatients. Arch Gen Psychiatry 1980;37:556-560.
7. Braithwaite R, Goulding R, Traeno G, Bailey J, Coppen A: Plasma concentration of amitriptyline and clinical response. Lancet 1972;1:1297-1300.
8. SAS Institute: SAS Users Guide: Statistics. Fifth edition. Cary, NC: SAS Institute, 1985.
9. Fleishaker JC, Phillips JP, Eller MG, Smith RB: PK-PD of alpra-zolam following single and multiple oral dose of a sustained release formulation. J Clin Pharmacol 1989;29:543-549.
10. Unverferth DV, Blanford M, Kates RE, Leier CV: Tolerance to dobutamine after a 72 hour continuous infusion. Am J Med 1980;69:262-266.
11. Porchet HC, Benowitz NL, Sheiner LB: Pharmacodynamic model of tolerance: application to nicotine. J Pharmacol Exp Ther 1988;244:231-236.
12. Gupta SK, Yih BM, Pardo B, Gorsline J, Rolf CN, Hwang SS: Pharmacokinetic and pharmacodynamic modelling of plasma nicotine concentrations and hemodynamic measurements for smoking and Nicoderm (nicotine transdermal system) (abstract). Pharm Res 1992;9(suppl):S355.
13. Shi J, Benowitz NL, Denaro CP, Sheiner LB: Pharmacokineticpharmacodynamic modeling of caffeine: tolerance to pressor effects. Clin Pharmacol Ther 1993;53:6-14.